An update on the biology of sphingosine 1-phosphate receptors
Open accessThe DOI matches its Crossref record; 180 of the 184 references it cites were found in a registry or an index.
Abstract
Sphingosine 1-phosphate (S1P) is a membrane-derived lysophospholipid that acts primarily as an ex-tracellular signaling molecule. Signals initiated by S1P are transduced by five G protein-coupled receptors, named S1P1-5 Cellular and temporal expression of the S1P receptors (S1PRs) determine their specific roles in various organ systems, but they are particularly critical for regulation of the cardiovascular, immune, and nervous systems, with the most well-known contributions of S1PR signaling being modulation of vascular barrier function, vascular tone, and regulation of lymphocyte trafficking. However, our knowledge of S1PR biology is rapidly increasing as they become attractive therapeutic targets in several diseases, such as chronic inflammatory pathologies, autoimmunity, and cancer. Understanding how the S1PRs regulate interactions between biological systems will allow for greater efficacy in this novel therapeutic strategy as well as characterization of complex physiological networks. Because of the rapidly expanding body of research, this review will focus on the most recent advances in S1PRs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas DCs express S1PR1, S1PR3 and S1PR4, T cells display S1PR1 and S1PR4 (refs164–166)”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [166]
Citations
Cites
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681
Cited by
Items 401–500 of 548
Thompson, J., Yang, Y., Duval, K., Griego, M. S., Chen, H., SantaCruz, K. S., Deng, H., Pérez, C., Maez, S., Hobson, S., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0098 · Cited by 9
“In addition to Akt, the downstream analysis has shown that S1PR 1 activation also involves the phosphorylation of extracellular signal-regulated kinases 1/2 (Erk1/2) via the G i/o /Ras/Erk1/2 pathway to promote a pre-survival effect [68, 69].”
InfluentialEgom, E. E. A., Shiwani, H. A., Pharithi, R. B., Canning, R., Khan, B. U., Hiani, Y. E., & Maher, V. M. G. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12888 · Cited by 4
“Several studies(26-28) have demonstrated that HDL may serve as a carrier for S1P, a lysosphingolipid exerting its biological actions mainly via the binding to five G proteincoupled receptors, named S1P1–5 (29-31).”
BackgroundThe safety and pharmacokinetics of a novel, selective S1P1R modulator in healthy participants
Singhal, S., Girgis, I. G., Xie, J., Dutta, S., Shevell, D. E., & Throup, J. P. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1742322 · Cited by 4
Sphingolipids: From structural components to signaling hubs
Issleny, B. M., Jamjoum, R., Majumder, S., & Stiban, J. (2023) · The Enzymes · doi:10.1016/bs.enz.2023.07.003 · Cited by 4
Sphingosine-1-phosphate transport and its role in immunology
Reitsema, V. A., Bouma, H. R., & Kok, J. W. (2014) · AIMS molecular science · doi:10.3934/molsci.2014.4.183 · Cited by 6
Kucharz, K., Janiurek, M. M., Christoffersen, C., & Lauritzen, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.11.487803 · Cited by 4
“First, the reduction in apoM is thought to shift the signaling equilibrium from S1PR1 to S1PR2 and S1PR3, which may act antagonistically to S1PR1 [19].”
BackgroundCritical Evaluation of Sphingolipids Detection by MALDI-MSIPreprint
Chen, B., Pathak, R., Subekti, A., Cheng, X., Singh, S., Ostermeyer‐Fay, A. G., Hannun, Y. A., Luberto, C., & Canals, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.04.636486 · Cited by 5
Mechanisms and potential therapeutic targets of SphK1 and SphK2 in hepatocellular carcinoma
Xu, X., Li, H., Li, R., Xu, Y., Xu, Y., Huang, H., Lv, X., Liao, C., Ye, J., & Bo, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1617401 · Cited by 5
Raeispour, M., Prisinzano, M., Seidita, I., Romeo, L., Nardi, E., Castiglione, F., Bruni, P., Petraglia, F., Bernacchioni, C., & Donati, C. (2025) · The FASEB Journal · doi:10.1096/fj.202502415r · Cited by 3
“Indeed, on the basis of the S1P “inside-out” mechanism of action, the sphingolipid generated following SK activation acts as a ligand of its receptors after being exported outside the cells [16, 17].”
S1PR-Targeted PET Imaging: Advancing Insights into Neuroinflammatory and Immune-Related Pathologies
Wu, R., Rong, J., Hou, Y., Yin, C., Zhou, Y. F., Gai, Y., Haider, A., Lan, X., Liang, S. H., Gao, Z., et al. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01259 · Cited by 3
Jiang, H., Huang, T., Yu, Y., Zhou, C., Qiu, L., Ngoc, H., Gropler, R. J., Klein, R. S., & Tu, Z. (2023) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2023.108370 · Cited by 3
Poteryaeva, O. N., & Усынин, И. Ф. (2024) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20247004206 · Cited by 4
Alsanafi, M., Kelly, S. L., McNaughton, M., Merrill, A. H., Pyne, N. J., & Pyne, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158631 · Cited by 3
Beyond biologics: advanced therapies in inflammatory bowel diseases
Caio, G., Lungaro, L., Chiarioni, G., Giancola, F., Caputo, F., Guarino, M., Volta, U., Testino, G., Pellicano, R., Zoli, G., et al. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02985-5 · Cited by 4
Fingolimod increases parvalbumin-positive neurons in adult mice
Ueno, H., Takahashi, Y., Murakami, S., Wani, K., Matsumoto, Y., Okamoto, M., & Ishihara, T. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.06.005 · Cited by 3
“Since fingolimod can cross the blood-brain barrier (BBB), it has potential effects on the cells of the CNS such as neurons, astrocytes, microglia, and oligodendrocytes (Blaho and Hla, 2014).”
BackgroundPepe, G., Cotugno, M., Marracino, F., Capocci, L., Pizzati, L., Forte, M., Stanzione, R., Scarselli, P., Pardo, A. D., Sciarretta, S., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159411 · Cited by 5
New markers in chronic obstructive pulmonary disease
Akdeniz, Y. S., & Özkan, S. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.06.001 · Cited by 6
Volk, L. M., Bruun, J.-E., Trautmann, S., Thomas, D., Schwalm, S. A., Pfeilschifter, J. M., & zu Heringdorf, D. M. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03027-7 · Cited by 4
“There are many examples for antagonistic signaling of S1P receptor subtypes [4].”
Morgan, T. E. F., Grant, E. K., Shaw, R., Waddell, L. J. N., Henry, M. C., McErlain, H., Alcaide-Corral, C. J., Pimlott, S. L., Tavares, A., & Sutherland, A. J. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00929k · Cited by 3
Inuki, S., Miyagawa, T., Oishi, S., & Ohno, H. (2018) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c18-00366 · Cited by 3
CERUTIS, D. R., Weston, M. D., & Miyamoto, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210278 · Cited by 2
“The bulk of S1P is transported bound to apolipoprotein M (apoM), with a much smaller percentage (30%) bound to albumin [62,63], which by contrast, serves as the major carrier for LPA.”
BackgroundNing, Y., Zhou, X., Wang, G., Zhang, L., & Wang, J. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998297749240418071555 · Cited by 3
Unraveling the Pleiotropic Role of High‐Density Lipoproteins (HDLs) in Autoimmune Rheumatic Diseases
Giacaglia, M. B., Pires, V., Santana, M. D. F. M., & Passarelli, M. (2024) · International Journal of Rheumatology · doi:10.1155/2024/1896817 · Cited by 2
“S1P modulates the acute-phase protein pentraxin 3 (PTX3), alters the di ff erentiation of lymphocyte lineage cells, and reduces dendritic cell activation and cell death, resulting in an anti-in fl ammatory phenotype [16, 17].”
Wencel, P. L., Blecharz‐Klin, K., Piechal, A., Pyrzanowska, J., Mirowska-Guzel, D. M., & Strosznajder, R. P. (2025) · Biomolecules · doi:10.3390/biom15111485 · Cited by 3
“It exerts its effects through five specific G-protein-coupled receptors (S1PR1–S1PR5) [8].”
Majrashi, T. A., Alsayari, A., Alshahrani, M. Y., Abohassan, M., Mohanto, S., Ahmad, M. Z., & Wahab, S. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02446-0 · Cited by 2
“Sphingosine-1-phosphate receptor 1 (S1PR1) is a class A GPCR highly expressed in endothelial cells and, to a lesser extent, in vascular smooth muscle cells, fibroblasts, melano - cytes, and epithelioid-derived cells (Lee et al. 2001; Hanson et al. 2012; Blaho and Hla 2014).”
The multifaceted significance of phosphoinositides in endocytic trafficking
Xie, C., & Shi, A. (2026) · FEBS Letters · doi:10.1002/1873-3468.70268 · Cited by 3
Wei, X., Yuan, K., Zhao, J., Gao, F., Li, J., Wang, Y., Hu, S., Xie, C., Liu, Y., Liu, H., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02690 · Cited by 2
Sakurai, T., & Saruta, M. (2026) · Internal Medicine · doi:10.2169/internalmedicine.7378-26 · Cited by 2
Ballarò, R., Lam, T., Pareek, S., Lee, J., Patel, H., Tirumala, P., Liu, G., Hayek, K., Savage, H., Maleki, R. D., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-4733 · Cited by 3
The Role of Lysophospholipids in Immune Cell Trafficking and Inflammation
Miyasaka, M., Takeda, A., Hata, E., Sasaki, N., Umemoto, E., & Jalkanen, S. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_35 · Cited by 3
Zeraatpisheh, Z., Shamsi, F., Sarkoohi, P., Torabi, S., Alipour, H., & Aligholi, H. (2022) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-022-00724-0 · Cited by 2
Park, B., Jeong, Y. S., Hu, W., Lee, M., Kim, J. C., Bae, G. H., Bae, Y., & Bae, Y.-S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1151511 · Cited by 2
“According to previous studies have shown abundant expression of S1PR3 in the nervous system, particularly in the dorsal root ganglion and astrocytes (38).”
BackgroundMacrophage polarization guided by immunomodulatory hydrogels
Francesco, D. D., Talmon, M., Carton, F., Fresu, L. G., & Boccafoschi, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823948-3.00020-8 · Cited by 2
Cohen, N. A., Weber, C. R., Cheng, J. X., Choi, D., Garcia, N. M., Choi, N. K., & Rubin, D. T. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad174 · Cited by 2
Riese, J., Kleinwort, A., Hannemann, M., Hähnel, C., Kersting, S., & Schulze, T. (2024) · European Journal of Immunology · doi:10.1002/eji.202350882 · Cited by 2
“…a bioactive sphingolipid that acts as an intra-and extra-cellular messenger and mediates a wide variety of biological cell functions (reviewed in [25, 26]), the majority of which, especially in the immune system, is regulated by its interaction with five membrane-bound G-protein–coupled receptors…”
Prisinzano, M., Seidita, I., Bruni, P., Petraglia, F., Bernacchioni, C., zu Heringdorf, D. M., & Donati, C. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111876 · Cited by 3
Shal, B., Griego, M. S., Yang, Y., Pérez, C., Sillerud, L. O., Deng, H., Akter, H., McChriston, J., Chen, H., Maez, S., et al. (2025) · Stroke · doi:10.1161/strokeaha.124.050452 · Cited by 3
Edison, J. D., Frattalone, S., Tracy, C., Woodard, G. E., Butts, M. S., & Moratz, C. M. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.10.005 · Cited by 2
Zhang, J., Bang, A., & Lye, S. J. (2017) · Methods in molecular biology · doi:10.1007/7651_2017_24 · Cited by 2
Neuroinflammation in Age-Related Neurodegenerative Diseases
MacPherson, K. P., Rodrigues, M. E. D. S., Cintron, A. F., & Tansey, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00016-x · Cited by 3
Inojosa, H., Eisele, J., Proschmann, U., Zeißig, S., Akgün, K., & Ziemssen, T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.567659 · Cited by 2
“While the S1P receptors S1P1, S1P2 and S1P3 are ubiquitously expressed, the subtypes S1P4 and S1P5 are restricted to certain cell types (Blaho and Hla, 2014).”
BackgroundThuy, A. V., Paul, J. J., Weigel, C., Ziegler, A. C., Guntinas‐Lichius, O., & Gräler, M. H. (2020) · Journal of Immunological Methods · doi:10.1016/j.jim.2020.112953 · Cited by 2
Nagarajan, S., Qian, Z. Y., Marimuthu, P., Alkayed, N. J., Kaul, S., & Barnes, A. P. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00335 · Cited by 2
Signaling Pathway Governed by Lipid Derived Molecules as Secondary Messenger
Kundu, D., & Halder, K. (2024) · International Journal of Advancement in Life Sciences Research · doi:10.31632/ijalsr.2024.v07i01.001 · Cited by 3
Specificity vs versatility: A fine balance for novel targeted molecular imaging radiotracers
Thackeray, J. T., & Bengel, F. M. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-016-0426-2 · Cited by 2
Sphingosine-1-phosphate (S1P) signaling as a novel therapeutic target for alcohol abusePreprint
Lorrai, I., Maccioni, R., Wu, C., Shankula, C. A., Gaytan, J. M., Torres, I., Puliga, R., Repunte‐Canonigo, V., & Sanna, P. P. (2025) · Research Square · doi:10.1101/2025.11.15.688635 · Cited by 2
Nishida, S., Matovelo, S. A., Kajimoto, T., Nakamura, S., & Okada, T. (2024) · Genes to Cells · doi:10.1111/gtc.13093 · Cited by 2
“Most of these processes are mediated by five S1P-specific G protein-coupled receptors (S1PR1-5) that exhibit distinct expression in tissues and cells and unique G protein-coupling patterns, which suggests distinctive cellular functions (Blaho & Hla, 2014; Bryan & Poeta, 2018; Rosen et al., 2009).”
BackgroundLang, J., Zhou, W., Huang, T., Jiang, H., Chen, H., Xu, S., Qiu, L., Heady, M., Yu, Y., Brier, M. R., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00881 · Cited by 1
Yuan, H., Xie, Z., Feng, M., Jianying, Z., Geng, R., Zhou, C., Lao, Q., & Huang, X. (2025) · Gynecologic and Obstetric Investigation · doi:10.1159/000546571 · Cited by 1
“S1P is a biologically active signaling lipid that plays crucial roles in processes of cell survival, proliferation, and migration, mostly mediated through its interaction with fi ve G protein-coupled receptors (S1PR1 – 5) [21 – 23].”
Kihara, Y., & Chun, J. J. M. (2025) · International Immunology · doi:10.1093/intimm/dxaf058 · Cited by 1
“More details about fingolimod are available (9, 11 – 15, 41, 42).”
InfluentialHuang, F., Yang, X., Wang, H., Shi, X., Zhao, X., Liu, J., Sun, Y., Song, X., Li, T., Li, Z., et al. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118487 · Cited by 1
Riese, J., Palankar, R., Wesche, J., Hannemann, M., Lührs, F., Hähnel, C., Kersting, S., & Schulze, T. (2026) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.12.019 · Cited by 1
Function and Modulation of Sphingosine-1-Phosphate Receptors in the Central Nervous System
Gulliksen, E., Darsi, S., Haidarbaigi, L., Codispoti, L. J., Purohit, D. J., Jung, A., Chilamula, A., & Newton, J. C. (2026) · Receptors · doi:10.3390/receptors5010009 · Cited by 1
“…analyses have demonstrated that the charged phosphate headgroup of S1P interacts with conserved basic residues near the extracellular face of the receptor, while the hydrophobic sphingoid tail extends into a lipid-accessible channel formed primarily by transmembrane helices III, V, and VI [11,111].”
Yamamura, K., Garcet, S., Gonzalez, J., Zhou, J., Fiedler, J., Miura, S., Williams, S. C., Hur, H. B., Murai‐Yamamura, M., Li, X., et al. (2026) · Allergy · doi:10.1111/all.70299 · Cited by 1
Low serum sphingosine-1-phospate and its chaperone ApoM associate with retinopathy of prematurity
Nilsson, A., Sjöbom, U., Panwar, M. B., Hellqvist, T., Fu, Z., Andersson, M. X., Pivodic, A., Smith, L. E. H., Ley, D., & Hellström, A. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101030 · Cited by 1
“This compartment-and receptor-specific dichotomy is consistent with the pleiotropic actions of S1P and the distinct roles of its receptors (55).”
Piga, I., Bonomo, R., Chinello, C., Pagani, L., Pacifico, P., & Meregalli, C. (2026) · Communications Medicine · doi:10.1038/s43856-026-01622-6 · Cited by 1
Zhao, X., Wang, L., Ren, S., Yang, Z., & Wu, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1824143 · Cited by 1
Casazza, K., Kartha, R. V., & Jarnes, J. R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114788 · Cited by 1
“In addition to glucosylceramide and lyso-Gb1 accumulation, disease-relevant downstream remodeling of ceramide, sphingosine, and S1P pools may shift cellular programs toward inflammatory activation and impaired homeostasis [59–61].”
Identifying lipid–protein interactomes with functional lipid probes
Farley, S. E., Guzman, G., Blume, B., Haberkant, P., Schultz, C., & Tafesse, F. (2026) · Nature Protocols · doi:10.1038/s41596-026-01405-2 · Cited by 1
Vascular Endothelial S1P2 Receptor Limits Tumor Angiogenesis and Hyperpermeability
Takuwa, N., Okamoto, Y., Yoshioka, K., & Takuwa, Y. (2015) · Springer eBooks · doi:10.1007/978-4-431-55669-5_17 · Cited by 1
Sphingosine-1-Phosphate and HDL Metabolism
Jiang, X., & Li, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812513-7.00007-0 · Cited by 1
Methods for Testing Immunological Factors
Braddock, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_45 · Cited by 1
Sphingosine 1‐Phosphate Prevents Human Embryonic Stem Cell Death Following Ischemic Injury
de Assis, J. L., Fernandes, A. M., Aniceto, B. S., Pompeu, P., Banchio, C., Girardini, J. E., Vieyra, A. R., Valverde, R. H. F., & Einicker‐Lamas, M. (2022) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.202200019 · Cited by 1
Sphingosine-1 Phosphate Receptor Modulators
Herrera, S., & Bodro, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-11363-5_12 · Cited by 1
Sphingosine-1-phosphate, its receptors, and their role in multiple sclerosis
COHAN, S. L., & Chen, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18578-6.00009-x · Cited by 1
New insights into the crosstalk between endocannabinoids and sphingosine-1-phosphate
Rapino, C., Standoli, S., Cencetti, F., Bruni, P., Oddi, S., & Maccarrone, M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110781 · Cited by 1
“In particular, AEA and 2-AG target cannabinoid receptors 1 and 2 (CB 1 and CB 2 ), whereas S1P activates five distinct receptors (S1PR 1–5 ) with both systems exhibiting overlapping anatomical distributions in the CNS and peripheral tissues (51–54).”
Inoue, S., Sakamoto, Y., Koami, H., Kosuke Yamada, C., Nagashima, F., Miike, T., Iwamura, T., & Obata, T. (2018) · Journal of Nippon Medical School · doi:10.1272/jnms.2018_85-6 · Cited by 1
S1P and LPA: Regulators of Immune Cell Egress and Ingress in Lymphoid Tissues
Miyasaka, M., Takeda, A., Hata, E., Sasaki, N., & Umemoto, E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.07019-3 · Cited by 1
Lee, K., Koh, E. H., Hong, C. H., Ko, M. S., Kim, J. H., Cho, H.-K., Lee, C., Yoon, J. E., Yun, J.-Y., Baek, I., et al. (2020) · doi:10.21203/rs.3.rs-96492/v1 · Cited by 1
S1P induces bleb-based T cell motility via S1PR1-dependent activation of RhoA and WNK1Preprint
Rodriguez, F. D. S., Belly, H. D., Zhang, Y., Strickland, E., Frazer, G. L., Ojukwu, J., Williamson, B. J., Weiner, O. D., & Burkhardt, J. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.03.680076 · Cited by 1
“Multiple S1PRs are expressed in different T cell subsets ( 47 ), some of which are known to activate RhoAthrough coupling to Ga12/13.”
Late-stage optimization of a tercyclic class of S1P3-sparing, S1P1 receptor agonists
Horan, J. C., Kuzmich, D., Liu, P., DiSalvo, D., Lord, J., Mao, C., Hopkins, T. D., Yu, H., Harcken, C., Betageri, R., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.090
8. Sphingosine-1-phosphate-rich high-density lipoprotein in cardiovascular health and disease
Egom, E. E. A. (2016) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-821-6_8
Rachid, C. V. M. (2016) · Americanae (AECID Library)
Effect of hypoxia on the cardiovascular sphingolipid system
Alganga, H. (2017) · Enlighten: Theses (The University of Glasgow)
Kerage, D. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3542jk56
Pyne, N. J., & Pyne, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00417
“S1P can be exported from cells [through transporter proteins such as Spns2 (2),MFsd2b (3), and someABC proteins (4)] to bind to a family of five S1P-specific G protein coupled receptors (S1P1−5) (5).”
BackgroundTHU0094 Role of sphingosine-1-phosphate receptor 3 signallingin collagen-induced arthritis
Inoue, T., Nagahara, H., Kaneshita, S., Kida, T., Kukida, Y., Fujioka, K., Wada, M., Kohno, M., & Kawahito, Y. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-eular.5329
Sphingosine 1‐Phosphate Signalling
Bernacchioni, C., Cencetti, F., Donati, C., & Bruni, P. (2019) · Wiley eBooks · doi:10.1002/9780470015902.a0028300
Izquierdo, M. C., Shanmugarajah, N., Lee, S. X., & Haeusler, R. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/804336
Maishan, M. (2018) · TSpace (University of Toronto)
zu Heringdorf, D. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-57401-7_10079
Lionakis, M. S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738066999.793580816
Kwon‐Chung, J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738066999.793580714
Carrié, L. (2023) · theses.fr (ABES) · doi:10.70675/eecd40a7z9c50z4d29z83b3z8659e4f94eb8 · Cited by 1
Methods for Testing Immunological Factors
Braddock, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-73317-9_149-1
Ayoubi, R., Fotouhi, M., Alende, C., Bolívar, S. G., Southern, K., Laflamme, C., & NeuroSGC/YCharOS/EDDU collaborative group (2024) · F1000Research · doi:10.12688/f1000research.153244.1
Ayoubi, R., Fotouhi, M., Alende, C., Bolívar, S. G., Southern, K., Laflamme, C., & NeuroSGC/YCharOS/EDDU collaborative group (2024) · F1000Research · doi:10.12688/f1000research.153244.2
Methods for Testing Immunological Factors
Braddock, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_149
Ayoubi, R., Fotouhi, M., Alende, C., Bolívar, S. G., Southern, K., Laflamme, C., & NeuroSGC/YCharOS/EDDU collaborative group (2025) · F1000Research · doi:10.12688/f1000research.153244.3
Amin, M. M., Zeyada, O. M., & Galal, R. E. S. A. M. (2025) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.401
Feher, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-820476-4.00017-5
Menna, F., Barbano, L., Dell’Aquila, C., D’Andrea, M., Parisi, V., & Ziccardi, L. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00854-3
“Additionally, dysfunction of vascular smooth muscle cells—mediated by disrupted S1P signalling—could impair extracellular matrix maintenance and further weaken the vessel wall, contributing to aneurysmal changes [26, 27].”
The Role of Sphingosine 1-phosphate and S1PR1-3 in the Pathophysiology of Meningococcal Meningitis
Fohmann, I. (2024) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-36976 · Cited by 2
Investigating chemical pollutants at the ‘druggable’ GPCRome
Wilkinson, J. C. (2024) · Iowa Research Online (The University of Iowa) · doi:10.25820/etd.007332
”Sphingosine 1-phosphate: a new player in uterine disorders”
Vannuzzi, V. (2023) · Florence Research (University of Florence)
Metadata
- Authors
- Blaho, V. A., & Hla, T.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Hla, Timothy
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 55
- Issue
- 8
- Pages
- 1596-1608
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC4109755
- OpenAlex
- W2005467120
- Cited by
- 516
- References
- 184
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 35 · 2023: 49 · 2022: 31 · 2021: 59 · 2020: 48 · 2019: 46 · 2018: 52 · 2017: 49 · 2016: 48 · 2015: 29 · 2014: 10
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2239 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- National Heart, Lung, and Blood Institute (R01HL067330, R37HL067330, R01HL089934, P01HL070694)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, lysophospholipids, vascular barrier function, vascular tone, lymphocyte migration, chronic inflammation, autoimmunity, cancer, therapeutic target
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Lysophospholipids, Neoplasm Proteins, Neoplasms, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.